US Stock MarketDetailed Quotes

ABCL AbCellera Biologics

Watchlist

3.000
+0.170+6.01%

Close Nov 27 16:00 ET

3.050
+0.050+1.67%

Post 20:02 ET

886.10MMarket Cap-4918P/E (TTM)

AbCellera Biologics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-27,147.17%-28.88M

-250.56%-29.97M

5.34%-41.71M

-115.82%-43.88M

-163.44%-19.61M

99.92%-106K

-92.71%19.9M

-143.97%-44.06M

13.40%277.36M

284.97%30.91M

Net income from continuing operations

-78.63%-51.11M

-20.97%-36.93M

-1.25%-40.61M

-192.35%-146.4M

-57.73%-47.15M

-207.46%-28.61M

-349.93%-30.53M

-123.79%-40.11M

3.29%158.52M

-149.86%-29.89M

Depreciation and amortization

416.87%38.3M

424.21%38.04M

-4.97%6.77M

-6.67%30.89M

-40.70%9.11M

10.12%7.41M

20.11%7.26M

43.17%7.12M

91.90%33.1M

215.85%15.36M

Deferred tax

----

192.72%1.96M

--8.31M

----

-4.76%-2.11M

----

Other non cash items

---9.61M

-5,034.59%-40.82M

146.97%1.71M

-190.57%-7.74M

----

-370.41%-795K

-513.85%-3.63M

139.41%8.55M

-11.87%5.24M

Change In working capital

-180.04%-5.73M

-129.14%-8.04M

-17.75%-26.98M

-55.66%13.23M

-95.14%1.41M

104.08%7.16M

-89.45%27.57M

73.05%-22.91M

-28.43%29.83M

130.68%28.99M

-Change in receivables

-76.79%-19.82M

50.73%-15.86M

-208.16%-18.58M

-134.44%-36.66M

-115.78%-10.44M

81.10%-11.21M

-111.65%-32.18M

109.72%17.18M

373.60%106.46M

148.11%66.17M

-Change in payables and accrued expense

-79.46%1.39M

-94.86%1.98M

76.74%-8.06M

-621.30%-15.1M

-166.41%-25.68M

105.69%6.78M

353.71%38.45M

-137.02%-34.65M

35.31%-2.09M

-27.28%38.68M

-Change in other current assets

-72.89%2.48M

73.33%2.13M

40.54%-3.61M

753.09%8.98M

3,228.19%4.66M

214.18%9.15M

-64.01%1.23M

19.77%-6.06M

59.33%-1.38M

-136.88%-149K

-Change in other working capital

318.42%10.22M

-81.50%3.71M

425.97%3.26M

176.55%56.01M

143.42%32.87M

2,141.28%2.44M

728.16%20.08M

-88.97%620K

-383.44%-73.16M

-616.63%-75.7M

Cash from discontinued investing activities

Operating cash flow

-27,147.17%-28.88M

-250.56%-29.97M

5.34%-41.71M

-115.82%-43.88M

-163.44%-19.61M

99.92%-106K

-92.71%19.9M

-143.97%-44.06M

13.40%277.36M

284.97%30.91M

Investing cash flow

Cash flow from continuing investing activities

128.92%3.7M

251.49%52.1M

119.99%29.91M

37.30%-221.11M

-42.55%-24.32M

95.47%-12.79M

-26.45%-34.39M

-467.32%-149.61M

-6.13%-352.63M

-1,385.03%-17.06M

Net PPE purchase and sale

8.93%-18.52M

26.07%-20.11M

-61.11%-24.14M

-8.90%-76.95M

-17.04%-14.43M

-62.48%-20.33M

13.16%-27.2M

-3.37%-14.98M

-20.89%-70.66M

-30.75%-12.33M

Net intangibles purchase and sale

----

72.00%-560K

----

---2M

--0

Net business purchase and sale

-101.52%-7.14M

-122.91%-4.91M

-32.18%-5.91M

46.69%-13.69M

41.17%-3.48M

13.13%-3.54M

70.05%-2.2M

46.38%-4.47M

38.54%-25.68M

-83.62%-5.91M

Net investment purchase and sale

431.15%19.95M

746.36%64.54M

139.74%52.79M

42.66%-155.22M

-1,294.13%-16.14M

101.39%3.76M

-266.92%-9.99M

-2,064.72%-132.85M

-2.30%-270.72M

89.77%-1.16M

Net other investing changes

28.24%9.4M

151.64%12.58M

166.17%7.17M

54.02%25.31M

340.79%10.29M

22.13%7.33M

-9.12%5M

3.74%2.69M

-49.62%16.43M

-89.77%2.33M

Cash from discontinued investing activities

Investing cash flow

128.92%3.7M

251.49%52.1M

119.99%29.91M

37.30%-221.11M

-42.55%-24.32M

95.47%-12.79M

-26.45%-34.39M

-467.32%-149.61M

-6.13%-352.63M

-1,385.03%-17.06M

Financing cash flow

Cash flow from continuing financing activities

-52.56%3.15M

532.70%2.65M

718.12%2.83M

736.12%10.36M

978.80%3.77M

34,994.74%6.63M

-64.28%419K

85.37%-458K

58.11%-1.63M

-80.97%349K

Net issuance payments of debt

----

320.69%11.59M

----

-49.79%2.76M

-96.46%349K

Proceeds from stock option exercised by employees

-11.33%227K

38.02%461K

82.04%892K

----

--256K

--334K

--490K

----

Net other financing activities

-54.22%2.92M

2,476.47%2.19M

304.54%1.94M

71.85%-1.23M

---6.75M

2,649.60%6.37M

-90.95%85K

81.31%-948K

53.24%-4.38M

--0

Cash from discontinued financing activities

Financing cash flow

-52.56%3.15M

532.70%2.65M

718.12%2.83M

736.12%10.36M

978.80%3.77M

34,994.74%6.63M

-64.28%419K

85.37%-458K

58.11%-1.63M

-80.97%349K

Net cash flow

Beginning cash position

-15.18%175.6M

-31.52%150.86M

-61.27%160.61M

-17.26%414.65M

-50.08%199.71M

-74.67%207.04M

-61.46%220.31M

-17.26%414.65M

-15.65%501.14M

-22.72%400.09M

Current changes in cash

-251.95%-22.04M

276.17%24.78M

95.38%-8.97M

-231.15%-254.63M

-382.92%-40.17M

98.47%-6.26M

-105.70%-14.07M

-374.52%-194.13M

16.01%-76.89M

188.59%14.2M

Effect of exchange rate changes

134.52%367K

-105.40%-43K

-266.67%-781K

106.14%589K

193.41%1.07M

87.57%-1.06M

166.03%797K

-4.41%-213K

-573.61%-9.6M

169.33%364K

End cash Position

-22.92%153.93M

-15.18%175.6M

-31.52%150.86M

-61.27%160.61M

-50.08%199.71M

-74.67%207.04M

-61.46%220.31M

-17.26%414.65M

Free cash flow

-131.92%-47.4M

-586.16%-50.08M

-11.52%-65.85M

-159.30%-121.38M

-286.21%-34.6M

85.54%-20.44M

-103.02%-7.3M

-168.88%-59.05M

9.98%204.7M

171.08%18.58M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-27,147.17%-28.88M	-250.56%-29.97M	5.34%-41.71M	-115.82%-43.88M	-163.44%-19.61M	99.92%-106K	-92.71%19.9M	-143.97%-44.06M	13.40%277.36M	284.97%30.91M
Net income from continuing operations	-78.63%-51.11M	-20.97%-36.93M	-1.25%-40.61M	-192.35%-146.4M	-57.73%-47.15M	-207.46%-28.61M	-349.93%-30.53M	-123.79%-40.11M	3.29%158.52M	-149.86%-29.89M
Depreciation and amortization	416.87%38.3M	424.21%38.04M	-4.97%6.77M	-6.67%30.89M	-40.70%9.11M	10.12%7.41M	20.11%7.26M	43.17%7.12M	91.90%33.1M	215.85%15.36M
Deferred tax	----	----	----	192.72%1.96M	--8.31M	----	----	----	-4.76%-2.11M	----
Other non cash items	---9.61M	-5,034.59%-40.82M	146.97%1.71M	-190.57%-7.74M	----	----	-370.41%-795K	-513.85%-3.63M	139.41%8.55M	-11.87%5.24M
Change In working capital	-180.04%-5.73M	-129.14%-8.04M	-17.75%-26.98M	-55.66%13.23M	-95.14%1.41M	104.08%7.16M	-89.45%27.57M	73.05%-22.91M	-28.43%29.83M	130.68%28.99M
-Change in receivables	-76.79%-19.82M	50.73%-15.86M	-208.16%-18.58M	-134.44%-36.66M	-115.78%-10.44M	81.10%-11.21M	-111.65%-32.18M	109.72%17.18M	373.60%106.46M	148.11%66.17M
-Change in payables and accrued expense	-79.46%1.39M	-94.86%1.98M	76.74%-8.06M	-621.30%-15.1M	-166.41%-25.68M	105.69%6.78M	353.71%38.45M	-137.02%-34.65M	35.31%-2.09M	-27.28%38.68M
-Change in other current assets	-72.89%2.48M	73.33%2.13M	40.54%-3.61M	753.09%8.98M	3,228.19%4.66M	214.18%9.15M	-64.01%1.23M	19.77%-6.06M	59.33%-1.38M	-136.88%-149K
-Change in other working capital	318.42%10.22M	-81.50%3.71M	425.97%3.26M	176.55%56.01M	143.42%32.87M	2,141.28%2.44M	728.16%20.08M	-88.97%620K	-383.44%-73.16M	-616.63%-75.7M
Cash from discontinued investing activities
Operating cash flow	-27,147.17%-28.88M	-250.56%-29.97M	5.34%-41.71M	-115.82%-43.88M	-163.44%-19.61M	99.92%-106K	-92.71%19.9M	-143.97%-44.06M	13.40%277.36M	284.97%30.91M
Investing cash flow
Cash flow from continuing investing activities	128.92%3.7M	251.49%52.1M	119.99%29.91M	37.30%-221.11M	-42.55%-24.32M	95.47%-12.79M	-26.45%-34.39M	-467.32%-149.61M	-6.13%-352.63M	-1,385.03%-17.06M
Net PPE purchase and sale	8.93%-18.52M	26.07%-20.11M	-61.11%-24.14M	-8.90%-76.95M	-17.04%-14.43M	-62.48%-20.33M	13.16%-27.2M	-3.37%-14.98M	-20.89%-70.66M	-30.75%-12.33M
Net intangibles purchase and sale	----	----	----	72.00%-560K	----	----	----	----	---2M	--0
Net business purchase and sale	-101.52%-7.14M	-122.91%-4.91M	-32.18%-5.91M	46.69%-13.69M	41.17%-3.48M	13.13%-3.54M	70.05%-2.2M	46.38%-4.47M	38.54%-25.68M	-83.62%-5.91M
Net investment purchase and sale	431.15%19.95M	746.36%64.54M	139.74%52.79M	42.66%-155.22M	-1,294.13%-16.14M	101.39%3.76M	-266.92%-9.99M	-2,064.72%-132.85M	-2.30%-270.72M	89.77%-1.16M
Net other investing changes	28.24%9.4M	151.64%12.58M	166.17%7.17M	54.02%25.31M	340.79%10.29M	22.13%7.33M	-9.12%5M	3.74%2.69M	-49.62%16.43M	-89.77%2.33M
Cash from discontinued investing activities
Investing cash flow	128.92%3.7M	251.49%52.1M	119.99%29.91M	37.30%-221.11M	-42.55%-24.32M	95.47%-12.79M	-26.45%-34.39M	-467.32%-149.61M	-6.13%-352.63M	-1,385.03%-17.06M
Financing cash flow
Cash flow from continuing financing activities	-52.56%3.15M	532.70%2.65M	718.12%2.83M	736.12%10.36M	978.80%3.77M	34,994.74%6.63M	-64.28%419K	85.37%-458K	58.11%-1.63M	-80.97%349K
Net issuance payments of debt	----	----	----	320.69%11.59M	----	----	----	----	-49.79%2.76M	-96.46%349K
Proceeds from stock option exercised by employees	-11.33%227K	38.02%461K	82.04%892K	----	----	--256K	--334K	--490K	----	----
Net other financing activities	-54.22%2.92M	2,476.47%2.19M	304.54%1.94M	71.85%-1.23M	---6.75M	2,649.60%6.37M	-90.95%85K	81.31%-948K	53.24%-4.38M	--0
Cash from discontinued financing activities
Financing cash flow	-52.56%3.15M	532.70%2.65M	718.12%2.83M	736.12%10.36M	978.80%3.77M	34,994.74%6.63M	-64.28%419K	85.37%-458K	58.11%-1.63M	-80.97%349K
Net cash flow
Beginning cash position	-15.18%175.6M	-31.52%150.86M	-61.27%160.61M	-17.26%414.65M	-50.08%199.71M	-74.67%207.04M	-61.46%220.31M	-17.26%414.65M	-15.65%501.14M	-22.72%400.09M
Current changes in cash	-251.95%-22.04M	276.17%24.78M	95.38%-8.97M	-231.15%-254.63M	-382.92%-40.17M	98.47%-6.26M	-105.70%-14.07M	-374.52%-194.13M	16.01%-76.89M	188.59%14.2M
Effect of exchange rate changes	134.52%367K	-105.40%-43K	-266.67%-781K	106.14%589K	193.41%1.07M	87.57%-1.06M	166.03%797K	-4.41%-213K	-573.61%-9.6M	169.33%364K
End cash Position	-22.92%153.93M	-15.18%175.6M	-31.52%150.86M	-61.27%160.61M	-61.27%160.61M	-50.08%199.71M	-74.67%207.04M	-61.46%220.31M	-17.26%414.65M	-17.26%414.65M
Free cash flow	-131.92%-47.4M	-586.16%-50.08M	-11.52%-65.85M	-159.30%-121.38M	-286.21%-34.6M	85.54%-20.44M	-103.02%-7.3M	-168.88%-59.05M	9.98%204.7M	171.08%18.58M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data